Literature DB >> 24081905

AKT3 controls mitochondrial biogenesis and autophagy via regulation of the major nuclear export protein CRM-1.

Daniel G Corum1, Philip N Tsichlis, Robin C Muise-Helmericks.   

Abstract

Our previous work has shown that Akt3 is required for mitochondrial biogenesis in primary human endothelial cells (ECs) and in Akt3-null mice; Akt3 affects subcellular localization of peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1α), the master regulator of mitochondrial biogenesis. The purpose of this study is to determine the mechanism by which Akt3 controls the subcellular distribution of PGC-1α and to explore the effect on mitochondrial biogenesis and turnover during angiogenesis. Here we use standard biochemical analyses and Akt3-knockdown strategies to show that Akt3 controls the stabilization of chromosome maintenance region-1 (CRM-1), the major nuclear export receptor. Site-directed mutagenesis and association analyses show that PGC-1α nuclear export is CRM-1 dependent. Akt3 knockdown and CRM-1 overexpression cause 3-fold reductions in PGC-1α target gene expression, compared to control levels. Akt3 inhibition causes autophagy, as measured by autophagosome formation, in a CRM-1-dependent, Akt1/mTOR-independent pathway. In vivo, Akt3-null and heterozygous mice show dose-dependent decreases in angiogenesis compared to wild-type littermates (~5- and 2.5-fold decreases, respectively), as assessed by Matrigel plug assays. This correlates with an ~1.5-fold decrease in mitochondrial Cox IV expression. Our studies suggest that Akt3 is a regulator of mitochondrial dynamics in the vasculature via regulation of CRM-1-dependent nuclear export.

Entities:  

Keywords:  angiogenesis; endothelial cells; mitophagy

Mesh:

Substances:

Year:  2013        PMID: 24081905      PMCID: PMC3868834          DOI: 10.1096/fj.13-235382

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  57 in total

Review 1.  Clinical applications of angiogenic growth factors and their inhibitors.

Authors:  N Ferrara; K Alitalo
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.

Authors:  Irit Adini; Isaac Rabinovitz; Jing Fang Sun; George C Prendergast; Laura E Benjamin
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

Review 3.  Autophagy: assays and artifacts.

Authors:  Sandra Barth; Danielle Glick; Kay F Macleod
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

4.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

5.  Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.

Authors:  Raelene Endersby; Xiaoyan Zhu; Nissim Hay; David W Ellison; Suzanne J Baker
Journal:  Cancer Res       Date:  2011-04-20       Impact factor: 12.701

6.  CRM1-mediated nuclear export: to the pore and beyond.

Authors:  Saskia Hutten; Ralph H Kehlenbach
Journal:  Trends Cell Biol       Date:  2007-02-20       Impact factor: 20.808

7.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

8.  PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons.

Authors:  Przemyslaw Wareski; Annika Vaarmann; Vinay Choubey; Dzhamilja Safiulina; Joanna Liiv; Malle Kuum; Allen Kaasik
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

9.  SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis.

Authors:  Marcia C Haigis; Chu-Xia Deng; Lydia W S Finley; Hyun-Seok Kim; David Gius
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

10.  A novel AKT3 mutation in melanoma tumours and cell lines.

Authors:  M A Davies; K Stemke-Hale; C Tellez; T L Calderone; W Deng; V G Prieto; A J F Lazar; J E Gershenwald; G B Mills
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more
  20 in total

1.  Nuclear LC3-positive puncta in stressed cells do not represent autophagosomes.

Authors:  Erin M Buckingham; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Biotechniques       Date:  2014-11-01       Impact factor: 1.993

2.  OverAKT3: tumor progression and chemoresistance.

Authors:  Ping Ji; Kristen M Turner; Wei Zhang
Journal:  Cell Cycle       Date:  2015-04-30       Impact factor: 4.534

Review 3.  The role of autophagy in vascular biology.

Authors:  Samuel C Nussenzweig; Subodh Verma; Toren Finkel
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

4.  Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.

Authors:  Rubí Viedma-Rodríguez; Ruth Ruiz Esparza-Garrido; Luis Arturo Baiza-Gutman; Miguel Ángel Velázquez-Flores; Alejandro García-Carrancá; Fabio Salamanca-Gómez; Diego Arenas-Aranda
Journal:  Tumour Biol       Date:  2015-04-11

5.  Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.

Authors:  Kristen M Turner; Youting Sun; Ping Ji; Kirsi J Granberg; Brady Bernard; Limei Hu; David E Cogdell; Xinhui Zhou; Olli Yli-Harja; Matti Nykter; Ilya Shmulevich; W K Alfred Yung; Gregory N Fuller; Wei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

6.  MiR-15a attenuates peripheral nerve injury-induced neuropathic pain by targeting AKT3 to regulate autophagy.

Authors:  Longxue Cai; Xianfa Liu; Qicai Guo; Qi Huang; Qiong Zhang; Zuohong Cao
Journal:  Genes Genomics       Date:  2019-11-17       Impact factor: 1.839

7.  Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.

Authors:  Changrim Lee; Hao Guo; Wannita Klinngam; Srikanth R Janga; Frances Yarber; Santosh Peddi; Maria C Edman; Nishant Tiwari; Siyu Liu; Stan G Louie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  Mol Pharm       Date:  2019-05-30       Impact factor: 4.939

8.  Astrocytic YAP Promotes the Formation of Glia Scars and Neural Regeneration after Spinal Cord Injury.

Authors:  Changnan Xie; Xiya Shen; Xingxing Xu; Huitao Liu; Fayi Li; Sheng Lu; Ziran Gao; Jingjing Zhang; Qian Wu; Danlu Yang; Xiaomei Bao; Fan Zhang; Shiyang Wu; Zhaoting Lv; Minyu Zhu; Dingjun Xu; Peng Wang; Liying Cao; Wei Wang; Zengqiang Yuan; Ying Wang; Zhaoyun Li; Honglin Teng; Zhihui Huang
Journal:  J Neurosci       Date:  2020-02-17       Impact factor: 6.167

9.  The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells.

Authors:  Tess V Dupre; Dorea P Jenkins; Robin C Muise-Helmericks; Rick G Schnellmann
Journal:  Biochem Pharmacol       Date:  2019-09-19       Impact factor: 5.858

10.  Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.

Authors:  Minjee Kim; Young Yeon Kim; Hye Jin Jee; Sun Sik Bae; Na Young Jeong; Jee-Hyun Um; Jeanho Yun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-13       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.